The dengue (DEN) viruses are positive-strand RNA viruses in the genus Flavivirus. Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are important human arboviral diseases caused by infection with one of four closely related but serologically distinct DEN viruses, designated DEN-1, DEN-2, DEN-3, and DEN-4 viruses. All four DEN serotypes are currently cocirculating throughout the subtropics and tropics, and genotypic variation occurs among isolates within a serotype. A real-time quantitative nucleic acid amplification assay has been developed to detect viral RNA of a single DEN virus serotype. Each primer-probe set is DEN serotype specific, yet detects all genotypes in a panel of 7 to 10 representative isolates of a serotype. In single reactions and in fourplex reactions (containing four primer-probe sets in a single reaction mixture), standard dilutions of virus equivalent to 0.002 PFU of DEN-2, DEN-3, and DEN-4 viruses were detected; the limit of detection of DEN-1 virus was 0.5 equivalent PFU. Singleplex and fourplex reactions were evaluated in a panel of 40 viremic serum specimens with 10 specimens per serotype, containing 0.002 to 6,000 equivalent PFU/ reaction (0.4 to 1.2 ؋ 10 6 PFU/ml). Viral RNA was detected in all viremic serum specimens in singleplex and fourplex reactions. Thus, this serotype-specific, fourplex real-time reverse transcriptase PCR nucleic acid detection assay can be used as a method for differential diagnosis of a specific DEN serotype in viremic dengue patients and as a tool for rapid identification and serotyping of DEN virus isolates.Dengue (DEN) viruses are a group of four closely related arboviruses in the genus Flavivirus, designated DEN-1, DEN-2, DEN-3, and DEN-4 viruses (7). Aedes aegypti is the primary mosquito vector of the DEN viruses, and humans are the primary host. As a result of the expansion of the range of A. aegypti in urban environments throughout the tropics and subtropics, transmission of DEN viruses has also increased, with an estimated 2.5 billion people at risk of infection (4, 7-9). As many as 100 million people per year may become infected, including approximately 400,000 cases of DEN hemorrhagic fever (DHF) and DEN shock syndrome (DSS), which are more serious manifestations often associated with secondary DEN virus infections (34). In areas of dengue hyperendemicity, all four of the DEN virus serotypes may be circulating simultaneously, and an increase in DHF and DSS has been reported in these areas (4, 7, 9, 10).The DEN viruses are closely related serologically; however, they are antigenically distinct, and primary infection by one DEN virus serotype does not protect against infection from another DEN virus serotype (8). The antibodies raised against the primary infecting DEN virus serotype may cross-react with the subsequent infecting DEN virus serotype and through opsomization may function to enhance the ability of the second DEN virus serotype to infect the host, in a process called antibody-dependent enhancement of infection (28). DHF and DSS...